X
GO

Providers, Labs and Schools

The following section was developed for Providers, Laboratories, and Schools to provide information and resources to increase knowledge and awareness of childhood lead poisoning in Iowa. Our aim is to also help you understand the important role you play in helping to prevent and treat childhood lead exposures. Through these pages you should be able to understand lead poisoning, how to identify risk in a patient population, how to help parents prevent lead exposure, know when and why children should be tested for lead, what services should be provided at each level, how to report test results, and provide recommendations to parents.

The following links will provide additional information on the following topics:

For more information on lead poisoning, contact the Iowa Childhood Lead Poisoning Prevention Program at 800-972-2026 or online at Contact Us.

Magellan LeadCare Recall Updates

September 14, 2021 - CDC Announcement: LeadCare Recall Update from Magellan

For the latest information on the Megellan LeadCare test kit recall by the FDA see the links below.  Information can be found on the expanded Class I recall of Magellan's LeadCare II Blood Lead Test Kits, LeadCare Plus Blood Lead Test Kits, and LeadCare Ultra Blood Lead Test Kits for the detection of lead in whole blood.

August 19, 2021 - CDC Announcement: Potential Shortage of Blood Lead Test Kits Following July 2021 Recall

The Center for Disease Control and Prevention (CDC) has expressed concerns about potential shortages of LeadCare® test kits used to analyze capillary blood lead samples from patients, following a recall on July 2, 2021. A shortage of LeadCare® test kits may result in fewer children receiving blood lead tests in their jurisdictions.

If LeadCare test kits are unavailable, CDC strongly recommends that healthcare providers not delay required blood lead testing for children. Blood lead testing can be done with either a venous or capillary blood sample, both of which can be submitted to a laboratory for analysis with higher complexity methods. Healthcare providers should contact laboratories for recommended blood collection supplies.

Public Health Considerations and Actions

Healthcare providers should continue to schedule and perform required blood lead tests for patients. A venous or capillary blood sample analyzed using higher complexity methods should be used if LeadCare® test kits are unavailable.

Public health professionals should work with healthcare providers in their jurisdictions to ensure patients receive their required blood lead tests. This outreach should include making providers aware of the need to conduct a capillary or venous test analyzed using higher complexity methods if LeadCare® test kits are unavailable.

By delaying blood lead testing for children due to the unavailability of LeadCare® test kits, children with higher blood lead levels risk not being identified and receiving necessary treatment and services.

If blood lead testing indicates blood lead levels above the current CDC Blood Level Reference Values (BLRV) and/or state or local action level, the healthcare provider or public health official should refer to CDC guidelines or state/local guidelines for appropriate follow-up action.

LeadCare devices should be used according to U.S. Food and Drug Administration (FDA) approvals. Currently, venous samples are not approved by the FDA to be analyzed with LeadCare devices.

The Iowa Department of Public Health Lead Poisoning Prevention Program is available to answer questions. Please use the above "Contact Us" link or call us at 800-972-2026 during regular business hours.

July 2021 CDC Alert regarding Magellan Lead Test Kit Recall

The CDC released a Health Alert on July 6, 2021 regarding the recall of some Magellan test kits used for Point of Care blood lead testing. The CDC alert can be found at https://emergency.cdc.gov/han/2021/han00445.asp

The Iowa Department of Public Health Lead Poisoning Prevention Program is available to answer questions. Please use the above "Contact Us" link or call us at 800-972-2026 during regular business hours.